U.S. Allocates $600 Million to Gavi for Vaccine Programs with New Conditions
The U.S. has released $600 million to Gavi for vaccination efforts, conditional on changes to vaccine formulations. This funding is critical for sustaining global immunization programs, particularly in low-income countries, and poses implications for contractors involved in vaccine procurement and distribution.